Showing 9501-9510 of 19185 results for "".
- Emerging Sensor Technologies in Gastrointestinal Diagnostics: Spotlight on Ingestible Capsuleshttps://reachmd.com/news/emerging-sensor-technologies-in-gastrointestinal-diagnostics-spotlight-on-ingestible-capsules/2484114/The FireFLI capsule, a firefly-inspired ingestible biosensor, could enable earlier, noninvasive detection of intestinal inflammation and ischemia—potentially shifting time-to-diagnosis for conditions often recognized too late. According to
- FDA Expands Sotatercept Indication for PAH: A Closer Look at Clinical Impactshttps://reachmd.com/news/fda-expands-sotatercept-indication-for-pah-a-closer-look-at-clinical-impacts/2484099/The U.S. Food and Drug Administration (FDA) has approved an expanded indication for WINREVAIR™ (sotatercept-csrk), offering new hope for adults with pulmonary arterial hypertension (PAH, WHO Group 1) at high risk for clinical worsening.
- Prenatal Air Pollution Exposure and Autism Risk: Clinical Insightshttps://reachmd.com/news/prenatal-air-pollution-exposure-and-autism-risk-clinical-insights/2484100/A sweeping new study of more than 2.1 million births in Ontario, Canada, has identified a significant association between prenatal exposure t
- Recent Advances in Wireless Retinal Prostheses: Visual Outcomes and Safety Insightshttps://reachmd.com/news/recent-advances-in-wireless-retinal-prostheses-visual-outcomes-and-safety-insights/2484112/In a world-first, researchers have restored meaningful vision to patients with advanced macular degeneration using a wireless retinal implant and high-tech glasses — a breakthrough that could transform the treatment of irreversible blindness. The clinical trial, led by Stanford Medi
- Impact of 2025 CPR Guidelines on Emergency Care and Resuscitation Educationhttps://reachmd.com/news/impact-of-2025-cpr-guidelines-on-emergency-care-and-resuscitation-education/2484101/In a significant move toward improving outcomes for infants and children experiencing cardiac emergencies, the American Academy of Pediatrics (AAP) and the American Heart Association (AHA) have jointly released
- Music Engagement and Cognitive Health: Insights from a 10,800-Participant Studyhttps://reachmd.com/news/music-engagement-and-cognitive-health-insights-from-a-10800-participant-study/2484103/Monash University analysis of 10,893 adults aged ≥70 found routine music engagement was linked to substantially lower dementia incidence—39% lower for always-listening and 35% lower for instrument players. According to
- Upadacitinib Demonstrates Rapid Improvement in AD Patients With Prurigo Noduleshttps://reachmd.com/news/upadacitinib-demonstrates-rapid-improvement-in-ad-patients-with-prurigo-nodules/2484113/A new interim analysis from the ADMIRE study, presented at the 2025 Fall Clinical Dermatology Conference, reported that upadacitinib yields rapid and sustained improvements in patients with moderate-to-severe atopic dermatitis (AD) complicated by prurigo nodules, o
- Skin Cancer Champions Launches Integrated Public, Private Communityhttps://reachmd.com/news/skin-cancer-champions-launches-integrated-public-private-community/2484106/The Skin Cancer Champions organization, led by dermatologists Emily Ruiz, MD, MPH, and Chrysalyne Schmults, MD, MSce, FAAD, announced the official launch of its integrated public and private community at skincancerchampions.org. The public platform expands the group’s reach by offering edu
- JAK Inhibition, Durable Repigmentation Strategies Among Vitiligo Advanceshttps://reachmd.com/news/jak-inhibition-durable-repigmentation-strategies-among-vitiligo-advances/2484093/Vitiligo has entered a new era of treatment innovation, according to Seemal Desai, MD, FAAD, who presented “Vitiligo Spotlight: A Closer Look at JAK Inhibitors” at the 2025 Fall Clinical Dermatology Conference. Dr. Desai characterized the current moment as a “Renaissance period” in vitilig
- Inflammation and Pain in Neurocritical Care: New Insights from Recent Researchhttps://reachmd.com/news/inflammation-and-pain-in-neurocritical-care-new-insights-from-recent-research/2484056/A recent study found that early systemic inflammatory markers did not predict ICU pain burden after aneurysmal subarachnoid hemorrhage (SAH); instead